These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Long-term treatment strategy in chronic obstructive pulmonary disease: how to change the course of the disease]. Devillier P, Salvator H, Roche N, Grassin-Delyle S, Naline E, Dorocant S, Neveu H. Presse Med; 2014 Dec; 43(12 Pt 1):1368-80. PubMed ID: 25455634 [Abstract] [Full Text] [Related]
6. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Hanania NA. Pulm Pharmacol Ther; 2008 Dec; 21(3):540-50. PubMed ID: 18280761 [Abstract] [Full Text] [Related]
7. Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β2-agonist bronchodilators. Skolnik NS, Nguyen TS, Shrestha A, Ray R, Corbridge TC, Brunton SA. Postgrad Med; 2020 Mar; 132(2):198-205. PubMed ID: 31900019 [Abstract] [Full Text] [Related]
8. [Inhaled corticosteroid/beta-2 agonist therapy in moderate COPD]. Yıldırım N. Tuberk Toraks; 2010 Mar; 58(2):192-201. PubMed ID: 20865575 [Abstract] [Full Text] [Related]
10. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD. Ohar JA, Donohue JF. Semin Respir Crit Care Med; 2010 Jun 29; 31(3):321-33. PubMed ID: 20496301 [Abstract] [Full Text] [Related]
11. [Practice guideline 'Medical treatment of COPD']. Dekhuijzen PN, Broeders ME, Tuut MK, Grol MH. Ned Tijdschr Geneeskd; 2008 Jun 28; 152(26):1465-8. PubMed ID: 18666664 [Abstract] [Full Text] [Related]
12. [Management of patients with stable COPD]. Toyoshima H, Yoshida M. Nihon Rinsho; 2003 Dec 28; 61(12):2163-9. PubMed ID: 14674327 [Abstract] [Full Text] [Related]
13. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies. Wise RA, Tashkin DP. Am J Med; 2007 Aug 28; 120(8 Suppl 1):S4-13. PubMed ID: 17678942 [Abstract] [Full Text] [Related]
14. Innovations to achieve excellence in COPD diagnosis and treatment in primary care. Fromer L, Barnes T, Garvey C, Ortiz G, Saver DF, Yawn B. Postgrad Med; 2010 Sep 28; 122(5):150-64. PubMed ID: 20861599 [Abstract] [Full Text] [Related]
15. Modifying the course of chronic obstructive pulmonary disease: looking beyond the FEV1. Zuwallack RL, Nici L. COPD; 2012 Dec 28; 9(6):637-48. PubMed ID: 22958136 [Abstract] [Full Text] [Related]
16. Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision. Bateman ED, Feldman C, O'Brien J, Plit M, Joubert JR, COPD Guideline Working Group of the South African Thoracic Society. S Afr Med J; 2004 Jul 28; 94(7 Pt 2):559-75. PubMed ID: 15283307 [Abstract] [Full Text] [Related]
17. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). Cecere LM, Slatore CG, Uman JE, Evans LE, Udris EM, Bryson CL, Au DH. COPD; 2012 Jun 28; 9(3):251-8. PubMed ID: 22497533 [Abstract] [Full Text] [Related]
18. Contemporary management of chronic obstructive pulmonary disease: scientific review. Sin DD, McAlister FA, Man SF, Anthonisen NR. JAMA; 2003 Nov 05; 290(17):2301-12. PubMed ID: 14600189 [Abstract] [Full Text] [Related]
19. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study. Wurst KE, Shukla A, Muellerova H, Davis KJ. COPD; 2014 Sep 05; 11(5):521-30. PubMed ID: 24945236 [Abstract] [Full Text] [Related]
20. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease? Salama RO, Young PM, Rogueda P, Lallement A, Iliev I, Traini D. Expert Opin Pharmacother; 2011 Aug 05; 12(12):1913-32. PubMed ID: 21714776 [Abstract] [Full Text] [Related] Page: [Next] [New Search]